ASCO GUIDELINES Bundle

Chemotherapy-Induced Peripheral Neuropathy

ASCO GUIDELINES App Bundle brought to you fcourtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1475454

Contents of this Issue

Navigation

Page 5 of 7

Summary of Recommendations Interventions Strength of recommendation Strength of the evidence Benefits Harms a Goshajinkigan (GJG) – Kampo medicine Moderate against Intermediate Low Low Metformin Moderate against Intermediate Low Low Minocycline Moderate against Intermediate Low Low Nimodipine Moderate against Intermediate No evidence of efficacy Moderate Omega 3 Moderate against Intermediate Low Low Org 2766 Moderate against Intermediate Low Low Retinoic Acid Moderate against Intermediate Low Moderate rhuLIF Moderate against Intermediate No evidence of efficacy Low Venlafaxine Moderate against Intermediate Moderate Moderate Vitamin B Moderate against Intermediate Low Low Vitamin E Moderate against Intermediate Low Low Treatment Acupuncture No recommendation Low Low Low Duloxetine Moderate for Intermediate Moderate Low Exercise No recommendation Low Low Low Gabapentin/ pregabalin No recommendation Low Low Low Topical Amitriptyline, Ketamine, +/- Baclofen (BAK) No recommendation Low Low Low Oral cannabinoids No recommendation Low Low Low Tricyclic antidepressants No recommendation Low Low Low Scrambler erapy No recommendation Low Low Low a "Harms" are based only on the results of the specific clinical trials in the previous tables and not on any other evaluations of the safety of these treatments.

Articles in this issue

Archives of this issue

view archives of ASCO GUIDELINES Bundle - Chemotherapy-Induced Peripheral Neuropathy